A headscratcher?
This morning CeQur the makers of the Simplicity patch pump announced they have raised $115 million in Series C5 financing. Per a company issued press release;
“Credit Suisse Entrepreneur Capital Ltd. and Endeavour Vision led the financing with significant participation from new investors, including Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Ypsomed Group (SWX: YPSN), Federated Hermes Kaufmann Funds, Kingdon Capital, and GMS Capital, as well as existing investors, Schroder & Co. Bank SA, and VI Partners.”
Notice in that group of investors are two real insulin pump companies, Tandem and Ypsomed. Going back to the release:
“CeQur Simplicity is designed . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
